^○Di Comite Gabriele¹, Bar-or Amit², Weinstock-guttman Bianca³, Mao-draayer Yang⁴, Cox Gina⁵, Cruz Linda-ali⁵, Meng Xiangyi⁵, Su Wendy⁵, Cohan L. Stanley⁶ (1.Novartis Pharma KK, Tokyo, Japan, 2.Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, 3.Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA, 4.Autoimmunity Center of Excellence, Multiple Sclerosis Center, University of Michigan, Ann Arbor, MI, USA, 5.Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 6.Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, OR, USA)

^○Hiroyuki Murai¹, Vera Bril², Tuan Vu³, Chafic Karam⁴, Stojan Peric⁵, Tomihiro Imai⁶, Masanori Takahashi⁷, Akiyuki Uzawa⁸, Antonio Guglietta⁹, Peter Ulrichts⁹, Tony Vangeneugden⁹, Kimiaki Utsugisawa¹⁰, Renato Mantegazza¹¹, James F. Howard¹² (1.International University of Health and Welfare, Japan, 2.Krembil Neuroscience Centre, 3.University of South Florida, 4.Hospital of the University of Pennsylvania, 5.Wroclaw Medical University, 6.Sapporo Medical University, 7.Osaka University, 8.Chiba University, 9.argenx, 10.Hanamaki General Hospital, 11.Fondazione Istituto Neurologico Carlo Besta, 12.The University of North Carolina)

^○Xichen Zhu^1,2, Tao Ma^1,2 (1.Department of Neurology, the Affiliated WuXi NO.2 People's Hospital of Nanjing Medical University, Wuxi, China, 2.Department of Neurology, WuXi NO.2 People's Hospital, Affiliated Wuxi Clinical College of of Nantong University, Wuxi, China)

^○Toshihiro Masaki¹, Anura Rambukkana² (1.Center for Medical Education, Teikyo University of Science, Japan, 2.MRC Centre for Regenerative Medicine, University of Edinburgh)

^○Manabu Araki¹, Jacqueline Palace², Ingo Kleiter³, Anthony Traboulsee⁴, Takashi Yamamura⁵, Francesco Patti⁶, Daniela Stokmaier⁷, Gaelle Klingelschmitt⁷, Thomas Kuenzel⁷, H.-christian Von Büdingen⁷, Jeffrey L Bennett⁸ (1.Kawakita General Hospital, Tokyo, Japan, 2.John Radcliffe Hospital, Oxford, United Kingdom, 3.Ruhr University Bochum, Bochum, Germany, 4.University of British Columbia, Vancouver, Canada, 5.National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 6.University of Catania, Catania, Italy, 7.F. Hoffmann-La Roche Ltd, Basel, Switzerland, 8.University of Colorado School of Medicine, Aurora, CO, USA)

^○Sunfa Cheng¹, Hirata Koichi², Takeshima Takao³, Sakai Fumihiko⁴, Imai Noboru⁵, Matsumori Yasuhiko⁶, Tatsuoka Yoshihisa⁷, Yoshida Ryuji⁸, Peng Cheng⁹, Mikol D.. Daniel¹ (1.Global Development, Amgen Inc., Thousand Oaks, CA, USA, 2.Headache Center, Department of Neurology, Dokkyo Medical University, 3.Headache Center, Department of Neurology, Tominaga Hospital, 4.Saitama International Headache Center, 5.Department of Neurology, Japanese Red Cross Shizuoka Hospital, 6.Sendai Headache and Neurology Clinic, 7.Department of Neurology, Tatsuoka Neurology Clinic, 8.Research & Development, Amgen K.K., 9.Global Biostatistical Science, Amgen Inc.)